Progentos Therapeutics
Watertown
About Progentos Therapeutics
Progentos Therapeutics develops an approach to treat multiple sclerosis that stimulates the body's natural repair mechanisms.
Company Facts
- Operating status: Active
- Company type: For Profit
- IPO status: Private
- Employees: 11 – 50
- Total funding: $65.0M
- Funding stage: Early Stage Venture
- Last round: Series A (May 2024)
- Website: progentos.com
- Phone: [email protected]
Industries & Categories
Life Science, Medical, Therapeutics
Canonical: https://fsome.com/organization/progentos-therapeutics-4699 · For the full interactive profile (charts, investors, team, acquisitions, press), please enable JavaScript.